发明名称 LIPID-DRUG COMPLEXES IN REVERSED LIQUID AND LIQUID CRYSTALLINE PHASES
摘要 A pharmaceutical is formulated to enable enhanced delivery across membrane barriers, permit solubilization, protect compounds from deactivation by thiol containing compounds in the body, and allow retention of the drug during transport to a desired site of activity. The pharmaceutical includes a complex of two moieties where at least one is pharmaceutically active and is larger than a single atom in size, and the second moiety, when combined with a cationic or anionic counterion forms either a pharmaceutically acceptable anionic or cationic surfactant or a pharmaceutically acceptable salt that has an octanol water partition coefficient of greater than about 100.
申请公布号 WO2004012680(A2) 申请公布日期 2004.02.12
申请号 WO2003US24512 申请日期 2003.08.06
申请人 LYOTROPIC THERAPEUTICS, INC. 发明人 ANDERSON, DAVID, M.
分类号 A61K;A61K47/48;B32B15/02 主分类号 A61K
代理机构 代理人
主权项
地址